Business ❯ Finance ❯ Investments ❯ Securities

Securities Litigation

Varonis Investors Urged to Act as March 9 Lead-Plaintiff Deadline Nears in Securities Class Action

Investors face a March 9 deadline to seek lead-plaintiff status over alleged misstatements on SaaS conversions that inflated ARR expectations.

Law Firms Seek Agilon Health Investors Ahead of March 2 Lead Plaintiff Deadline in Securities Case

Varonis Investors Face March 9 Lead Plaintiff Deadline in Securities Class Action

Blue Owl Investors Face Feb. 2 Deadline in SDNY Securities Class Action Over Alleged Liquidity Misstatements

Primo Brands Securities Class Action Nears Jan. 12 Lead-Plaintiff Deadline

Stride Investors Face Jan. 12 Deadline in Securities Class Action Over Enrollment Claims and Tech Failure

Stride Securities Class Action Intensifies Ahead of Jan. 12 Lead‑Plaintiff Deadline

Blue Owl Securities Class Action Centers on BDC Redemption Strain as Firms Urge Investors to Act by Feb. 2

Firefly Aerospace Faces Securities Class Action Over IPO Claims as Shares Slide

Bitdeer Investors Urged to Consider Lead Role in Securities Case as Filing Deadline Approaches

James Hardie Investors Face Dec. 23 Lead‑Plaintiff Deadline in Securities Suit Over Alleged Destocking Cover‑Up

Stride Investors Sought for Lead Roles in Securities Suits Over Alleged Enrollment Inflation and Tech Failures

aTyr Investors Face Dec. 8 Deadline in Securities Suits Over Efzofitimod Trial Failure

Stride Investors Face Jan. 12 Deadline to Seek Lead Role in Securities Suit Alleging Inflated Enrollment

Alexandria Faces Securities Class Action Over LIC Disclosures After Q3 Write-Down

Molina Healthcare Investors Face Dec. 2 Deadline to Seek Lead Role in Securities Class Action

Freeport-McMoRan Faces Investor Class Action Over Grasberg Mine Safety Disclosures

Stride Faces Securities Class Action Over Alleged Inflated Enrollments After Sharp Stock Plunge

Savara Investors Pressed to Meet Class-Action Deadlines Over Alleged MOLBREEVI BLA Deficiencies

Stride Faces Investor Probes After Enrollment Shortfall Disclosure